MetLife Inc. (NYSE:MET) – Langen Mcalenn boosted their FY2016 earnings per share (EPS) estimates for MetLife in a report issued on Tuesday. Langen Mcalenn analyst L. Greenberg now expects that the firm will post earnings per share of $4.67 for the year, up from their prior estimate of $4.49. Langen Mcalenn also issued estimates for MetLife’s Q1 2017 earnings at $1.33 EPS, Q3 2017 earnings at $1.47 EPS, Q4 2017 earnings at $1.51 EPS and FY2017 earnings at $5.70 EPS.

A number of other research analysts have also recently commented on the stock. Argus reiterated a “buy” rating and set a $54.00 price target on shares of MetLife in a research report on Tuesday. JPMorgan Chase & Co. reiterated a “buy” rating and set a $51.00 price target on shares of MetLife in a research report on Friday, November 4th. FBR & Co reiterated a “buy” rating on shares of MetLife in a research report on Thursday, November 3rd. TheStreet upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research report on Friday, October 28th. Finally, Zacks Investment Research cut shares of MetLife from a “hold” rating to a “sell” rating in a research report on Wednesday, October 26th. One research analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $51.64.

Earnings History and Estimates for MetLife (NYSE:MET)

Shares of MetLife (NYSE:MET) opened at 53.74 on Wednesday. The company has a market capitalization of $59.07 billion, a price-to-earnings ratio of 16.51 and a beta of 1.66. The company’s 50 day moving average is $46.37 and its 200 day moving average is $43.62. MetLife has a one year low of $35.00 and a one year high of $54.98.

MetLife (NYSE:MET) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $1.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.04. The company had revenue of $17.70 billion for the quarter, compared to analyst estimates of $17.03 billion. MetLife had a net margin of 5.58% and a return on equity of 6.99%. The firm’s revenue was down 99.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.62 EPS.

Several institutional investors have recently modified their holdings of the stock. Commonwealth Bank of Australia increased its stake in MetLife by 6.1% in the second quarter. Commonwealth Bank of Australia now owns 212,847 shares of the company’s stock valued at $8,480,000 after buying an additional 12,150 shares during the last quarter. Deprince Race & Zollo Inc. increased its stake in MetLife by 6.7% in the second quarter. Deprince Race & Zollo Inc. now owns 722,124 shares of the company’s stock valued at $28,762,000 after buying an additional 45,507 shares during the last quarter. Hermes Investment Management Ltd. increased its stake in MetLife by 12.3% in the second quarter. Hermes Investment Management Ltd. now owns 393,115 shares of the company’s stock valued at $15,658,000 after buying an additional 43,100 shares during the last quarter. Douglas Lane & Associates LLC increased its stake in MetLife by 4.6% in the second quarter. Douglas Lane & Associates LLC now owns 1,150,985 shares of the company’s stock valued at $45,844,000 after buying an additional 50,215 shares during the last quarter. Finally, Adage Capital Partners GP L.L.C. increased its stake in MetLife by 4.0% in the first quarter. Adage Capital Partners GP L.L.C. now owns 1,636,668 shares of the company’s stock valued at $71,915,000 after buying an additional 63,700 shares during the last quarter. Hedge funds and other institutional investors own 74.50% of the company’s stock.

In other news, EVP Maria R. Morris sold 8,800 shares of the firm’s stock in a transaction on Tuesday, October 4th. The stock was sold at an average price of $45.00, for a total transaction of $396,000.00. Following the completion of the transaction, the executive vice president now directly owns 116,409 shares in the company, valued at $5,238,405. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Maria R. Morris sold 2,200 shares of the firm’s stock in a transaction on Tuesday, November 1st. The shares were sold at an average price of $47.33, for a total value of $104,126.00. Following the transaction, the executive vice president now owns 109,809 shares of the company’s stock, valued at $5,197,259.97. The disclosure for this sale can be found here. Insiders own 0.27% of the company’s stock.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 13th. Stockholders of record on Monday, November 7th will be issued a dividend of $0.40 per share. The ex-dividend date is Thursday, November 3rd. This represents a $1.60 annualized dividend and a dividend yield of 2.98%. MetLife’s payout ratio is presently 49.23%.

About MetLife

MetLife, Inc (MetLife) is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include Retail; Group, Voluntary & Worksite Benefits; Corporate Benefit Funding; Latin America (collectively, the Americas); Asia, and Europe, the Middle East and Africa (EMEA).

5 Day Chart for NYSE:MET

Receive News & Stock Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related stocks with our FREE daily email newsletter.